Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Puritan's Pride Steadily Expands Its Global Influence, Securing a Leading Position Among Nutritional Brands
2024-03-06 21:37
OnCusp Therapeutics Announces First Patient Dosed in Phase 1 Trial of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
2024-03-06 21:00
APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation
2024-03-06 20:22
Latest Updates of Viva Biotech's Portfolio Companies
2024-03-06 19:33
American, Finnish and Canadian governments fund oxygen plant at Tatu City SEZ, Kenya
2024-03-06 18:48
Akeso Announced the First Patient Dosed in Phase III Trial of Cadonilimab(PD-1/CTLA-4) Combined with Chemotherapy versus Tislelizumab Combined with Chemotherapy in First-line Treatment of PD-L1 negative NSCLC
2024-03-06 18:07
MAG GROUP HOLDING RECORDS OVER AED 12.6 BILLION SALES IN 2023
2024-03-06 18:00
NIPPON EXPRESS HOLDINGS Acquires Stake in Instalimb, Japan's Startup Expanding 3D-printed Prosthetics Business Overseas
2024-03-06 14:00
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina's Growth Vision
2024-03-06 12:29
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024
2024-03-06 08:59
AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting
2024-03-06 08:59
Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma
2024-03-06 08:45
Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms
2024-03-06 08:30
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024
2024-03-06 05:30
Life Fitness Delivers on the Future of Fitness, Debuting State-of-the-Art Cardio Line with Next-Gen Biomechanics, Symbio™, at IHRSA 2024
2024-03-06 00:00
Datasea Expects Approximately 1,128% Revenue Growth in 2024
2024-03-05 23:45
DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador
2024-03-05 22:00
Laifen Launches the Laifen Wave Electric Toothbrush, a Revolutionary New Oral Health and Wellness Experience
2024-03-05 22:00
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production
2024-03-05 22:00
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment
2024-03-05 21:00
1
121
122
123
124
125
1598